ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Thanks Silvr, hard to tell what is in play. The CVR's were likely something that would of been actioned had the CV reduction patent been granted. As you stated, now waiting for them to expire benefits the majority of shareholders and is likely what is happening.

They now have to publish the Clinical Trial results by October 27, 2023. The results will likely be presented at the American Heart Association Scientific Session November 11 to 13. Registration opens July 2023, so I expect it would list ANIP or the partner to be scheduled.